首页> 美国卫生研究院文献>Archives of Disease in Childhood >Bronchial responsiveness and lung function in infants with lower respiratory tract illness over the first six months of life.
【2h】

Bronchial responsiveness and lung function in infants with lower respiratory tract illness over the first six months of life.

机译:在生命的头六个月内患有下呼吸​​道疾病的婴儿的支气管反应性和肺功能。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to determine whether increased bronchial responsiveness to histamine is associated with lower respiratory tract illness (one or more episodes of wheeze or cough, or both) in infancy. Fifty four normal newborn infants who had at least one atopic parent were recruited. At a median age of 6.5 months, 45 infants, 23 with a history of lower respiratory tract illness, and 22 without, underwent pulmonary function testing during a symptom free period. The maximum flow at functional residual capacity (VmaxFRC) was calculated from partial forced expiratory flow volume curves using the squeeze technique. Bronchial responsiveness to increasing doses of histamine was assessed by determining the provoking concentration which caused a 30% decrease in VmaxFRC (PC30). The length adjusted VmaxFRC was lower for symptomatic infants before the challenge (median 125 ml/s; 95% confidence intervals (CI) 85 to 164 ml/s) compared with control infants (median 215 ml/s; 95% CI 159 to 298 ml/s). There was no significant difference in PC30 between symptomatic infants (median 10.3 g/l; 95% CI 2.8 to 23.8 g/l) and control infants (median 16.5 g/l; 95% CI 2.4 to 27.9 g/l). Bronchial responsiveness to histamine can be shown in most infants early in life and is independent of lower respiratory tract symptoms including wheezing.
机译:这项研究的目的是确定婴儿期支气管对组胺的反应性是否与下呼吸道疾病(一次或多次喘鸣或咳嗽,或两者兼有)相关。招募了具有至少一个异位父母的54名正常新生儿。在无症状时期,中位年龄为6.5个月,有45例婴儿,23例有下呼吸道疾病史和22例无呼吸史。使用挤压技术根据部分强制呼气流量曲线计算功能残余容量下的最大流量(VmaxFRC)。通过确定引起VmaxFRC(PC30)降低30%的刺激性浓度来评估支气管对增加组胺剂量的反应性。症状婴儿在攻击前的长度调整后的VmaxFRC较低(中位数125 ml / s; 95%置信区间(CI)85至164 ml / s),而对照婴儿(中位数215 ml / s; 95%CI 159至298)毫升/秒)。有症状婴儿(中位数10.3 g / l; 95%CI 2.8至23.8 g / l)和对照组婴儿(中位数16.5 g / l; 95%CI 2.4至27.9 g / l)之间的PC30差异无统计学意义。多数婴儿在生命早期就表现出对组胺的支气管反应性,并且与下呼吸道症状(包括喘息)无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号